R

Rajavani VH Surangi's
email & phone

Opt-Out

Current Position:

Senior Director, Global Lead Medical Review, Clinical Safety and Pharmacovigilance, US CSPV at Daiichi Sankyo US

Experience:

11 years

Location:

Raleigh-Durham-Chapel Hill Area

How to contact Rajavani VH Surangi

Last updated:2025-07-15
emailr**@daiichisankyo.us
phone+1-***-***-5955
LinkedIn
Facebook
Instagram
Pinterest

Analytics

According to LinkedIn Rajavani VH Surangi started working on 2014, then the employee has changed 4 companies and 6 jobs. On average, Rajavani VH Surangi works for one company for 1 year 5 months. Rajavani VH Surangi has been working as a Senior Director, Global Lead Medical Review, Clinical Safety and Pharmacovigilance, US CSPV for Daiichi Sankyo, Inc. for 1096 days. If you are interested in this candidate, contact him directly by using contact details provided by SignalHire.

Work Experience

Senior Director, Global Lead Medical Review, Clinical Safety and Pharmacovigilance, US CSPV at Daiichi Sankyo US

Aug 2022 - Current

Senior Medical Director at PPD part of Thermo-fisher Scientific

May 2022 - Aug 2022

Medical Director at PPD

Apr 2020 - May 2022

Associate Medical Director, M-SERM at PPD

Mar 2017 - Apr 2020

Senior Medical Data Specialist at Eisai US

Mar 2016 - Feb 2017

Senior PV Specialist at Ferring Pharmaceuticals through Advanced Clinical

Mar 2015 - Apr 2015

Senior Medical Data Specialist Oncology PCU at Eisai US

Jul 2014 - Feb 2015

Education

Doctor of Medicine (MD) at Andhra Medical College, NTR University of Health Sciences, Andhra Pradesh,India

Current Company Information Daiichi Sankyo US

Name: Daiichi Sankyo US

Speciality: Daiichi Sankyo, Inc. is a member of the Daiichi Sankyo group of companies and is focused on the development of oncology therapies and specialty medicines., Oncology, Specialty Medicine

Location: Basking Ridge, NJ, United States

Employees: 10000+

Description: At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting edge science and technology with a genuine interest in people, we develop high quality,...

Frequently Asked Questions

How long has Rajavani VH Surangi been working as a Senior Director, Global Lead Medical Review, Clinical Safety and Pharmacovigilance, US CSPV?

Rajavani VH Surangi's total experience in various companies as a Senior Director, Global Lead Medical Review, Clinical Safety and Pharmacovigilance, US CSPV 3 years.

What is Rajavani VH Surangi's minimum period of employment in the companies?

Rajavani VH Surangi's minimum period of employment in various companies is 1 month.

What is Rajavani VH Surangi's average duration of employment for different companies?

On average, Rajavani VH Surangi works for one company for 1 year 2 months

What industries has Rajavani VH Surangi worked in?

Rajavani VH Surangi works in the Pharmaceuticals. Previously, Rajavani VH Surangi worked in the Research.

What positions has Rajavani VH Surangi held before?

Previously, Rajavani VH Surangi worked as a Senior Medical Director, and Medical Director, and Associate Medical Director, M-SERM, and Senior Medical Data Specialist, and Senior PV Specialist.

How do I contact Rajavani VH Surangi?

Rajavani VH Surangi's email address is r**@daiichisankyo.us, phone number is +1-***-***-5955. Sign up to get contact details.

Who is the President & CEO of the Daiichi Sankyo US?

The President & CEO of the Daiichi Sankyo US is Ken Keller
Not the Rajavani VH Surangi you were looking for?

Find email for 850M+ professionals

Rajavani VH Surangi Namesakes

Name
Company
Position

Other employees at Daiichi Sankyo US

Name
Company
Position
M
Director, Publications Global Specialty Medical Affairs
F
Associate Director, External Supplier QA GMP
L
Executive District Manager Oncology
E
Sr Workplace Solutions Specialist
J
Manager, Scientific Operations
J
Associate Director, Market Access - Oncology
M
Associate Director, statistical programming
L
Associate Director, Clinical Sciences Oncology
T
Manager, Global Medical Content and Training, Global Medical Affairs
BACK TO TOP